A possible cause for that increase in the liver could be the increased LPC levels in NAFLD patients [190], given that LPC was found to be a potent stimulus of ATX in Heps [152]. The gene discussed is ENPP2; the disease is metabolic dysfunction-associated steatotic liver disease.